Premium-based site launches on October 18th during the BIO Investor Forum;
BIO is BioWeekSF’s inaugural “Welcome” Partner
SAN FRANCISCO, Sept. 28, 2017 -- Big3Bio, the leading aggregator service for the top three life sciences hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the upcoming launch of BioWeekSF (BioWeekSF.com), a premium website dedicated to optimizing the experience of attendees for the week of the J.P. Morgan Healthcare Conference in San Francisco, January 7-12, 2018 (“JPM Week”).
BioWeekSF is a valuable, must-have resource for JPM Week attendees, providing exclusive discounts, important news and updates, a portal to all events, customized consulting services, and more for this gathering of more than 40,000 investors, company executives, analysts, bankers, journalists, and other interested parties.
“Last year, our ‘On Your Mark: 2017’ guide for JPM Week was very well received, and our most downloaded publication,” says Tilton Little, publisher of Big3Bio. “This year we are building on that success with BioWeekSF, the ultimate resource for JPM Week participants.”
Big3Bio is also proud to announce that the Biotechnology Innovation Organization (BIO) has signed on as BioWeekSF’s inaugural “Welcome” Partner. To benefit the biotech community, BIO is offering complimentary access to the BIO One-on-One Partnering™ system during JPM Week to make it easier and more affordable to partner in downtown San Francisco.
“BIO One-on-One Partnering will allow you to request and schedule meetings with biotechs, investors, in-licensors, and others, saving you time and energy coordinating meetings during the jam-packed JPM Week,“ says Willie Reaves, director of Partnering Products & Services at BIO. “We look forward to working with Big3Bio to provide this free resource to BioWeekSF members.”
BioWeekSF will launch on October 18th during the BIO Investor Forum in San Francisco, along with an invite-only reception. The site will run from October 18 through JPM Week at a rate of $99 per individual membership. As a special part of its premium content, BioWeekSF will offer access to all types of experts who can answer specific questions and guide both sides of the partnering and fundraising table.
“Attending JPM Week is a must for almost everyone in the business of biopharma and healthcare,” says Little. “They go to sow the seeds of potential partnerships, seek investors, or just to create visibility in an increasingly crowded space. BioWeekSF will make sense out of this chaos and deliver a great overall value for attendees during this crucial week.”
BioWeekSF, BIO, and BIO’s provision of the BIO One-on-One Partnering™ system are not affiliated with J.P. Morgan or the J.P. Morgan Healthcare Conference.
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
About Big3Bio
Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives. More information is available at www.bigcom.bio. Subscribe to the Big3Bio newsletters at www.big3bio.com.
Contact: Robert Slocumb [email protected]


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 



